| Cat. No. |
Product Name |
Information |
| PC-23578 |
Licochalcone A
UGT inhibitor
|
Licochalcone A is a broad-spectrum inhibitor of UDP-glucuronosyltransferase (UGT) with IC50/Ki values of <5 uM for UGT1A1、1A3、1A4、1A6、1A7、1A9 and 2B7, shows anti-cancer effects, |
| PC-23567 |
ENPP1 inhibitor VIR3
ENPP1 inhibitor
|
VIR3 is a potent, orally bioavailable Enpp1 with IC50 of <0.75 nM for ENPP1 cGAMP hydrolysis activity inhibition in in vitro assays. |
| PC-23564 |
DRI-C21041
CD40-CD40L inhibitor
|
DRI-C21041 is a specific small molecule inhibitor of CD40-CD40L costimulatory interaction with IC50 of 0.31 uM in cell-free in vitro binding inhibition assay. |
| PC-23563 |
DRI-C21095
CD40-CD40L inhibitor
|
DRI-C21095 is a specific small molecule inhibitor of CD40-CD40L costimulatory interaction with IC50 of 0.17 uM in cell-free in vitro binding inhibition assay. |
| PC-23558 |
LZX-2-73
NUPR1 inhibitor
|
LZX-2-73 is a specific and effective NUPR1 inhibitor with Kd of 2.7 uM, inhibits MIA PaCa-2 cell proliferation with IC50 of 10.9 uM. |
| PC-23557 |
AJO14
NUPR1 inhibitor
|
AJO14 is a specific and effective NUPR1 inhibitor with Kd of 4.9 uM. |
| PC-23556 |
Purpurin
GDH1 inhibitor
|
Purpurin is a potent, specific inhibitor of glutamate dehydrogenase 1 (GDH1/GLUD1) with Ki of 1.9 uM, inhibits cancer cell proliferation and tumor growth. |
| PC-23555 |
R162
GDH1 inhibitor
|
R162 is a potent, specific inhibitor of glutamate dehydrogenase 1 (GDH1/GLUD1) with Ki of 28.6 uM, inhibits cancer cell proliferation and tumor growth. |
| PC-23544 |
LH1513
CaOx crystallization inhibitor
|
LH1513 (L-Lysine Dioxalate) is potent inhibitor of calcium oxalate (CaOx) crystallization with EC50 of 21.7 uM. |
| PC-23540 |
FPD5
Esterase D inhibitor
|
FPD5 is a small molecule activator of esterase D (ESD) with KD value of 0.8 nM, directly binds to ESD at Lys180 rather than its ubiquitination site Lys213. |
| PC-23538 |
WYFA15
SMS1 inhibitor
|
WYFA15 is a small molecule inhibitor of sphingomyelin synthase 1 (SMS1), inhibits severe fever with thrombocytopenia syndrome virus (SFTSV) infection and reduces SARS-CoV-2 replication and pathogenesis. |
| PC-23530 |
ROR1 inhibitor 19h
ROR1 inhibitor
|
ROR1 inhibitor 19h is a potent, specfic inhibitor of receptor tyrosine kinase-like orphan receptor 1 (ROR1) with SPR KD of 1.1 μM, exhibits antitumor activity in lung cancer and breast cancer cell lines (IC50: 0.36-1.37 μM). |
